Shocking new evidence has come to light of massive profiteering from cancer drugs - one cancer drug that costs only £99 to make is being being sold for up to £83,000, despite R&D costs being paid back over 10 years years ago.

News about a promising new breast cancer treatment combining Herceptin and Tyverb is dampened by the prospect that the drugs may be too expensive for the NHS.

Search Sidebar Widget Area

Please login and add some widgets to this widget area.

About Dying for a Cure

Dying for a Cure is a campaign, which is calling on the UK Government to reform the whole process for developing cancer drugs, so that it focuses on maximising benefits for patients rather than profits.
The campaign was started by John Piears, who lost his wife to ovarian cancer in October 2015. You can read more about John's inspiration for the campaign in our article Cancer Tug of War